INCELLDX INC has a total of 45 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, computer technology and measurement are ADVANCED BIOMEDICAL LTD, MATSUMOTO TORU and TOHOKU DENSHI SANGYO KK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | China | 6 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Japan | 3 | |
#6 | Hong Kong | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Costa Rica | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Measurement | |
#4 | Pharmaceuticals | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Electric digital data processing | |
#4 | Healthcare informatics | |
#5 | Bioinformatics | |
#6 | Therapeutic chemical compounds | |
#7 | Heterocyclic compounds | |
#8 | Peptides | |
#9 | Microbiology | |
#10 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Patterson Bruce K | 34 |
#2 | Chargin Amanda Noel | 19 |
#3 | Shults Keith | 14 |
#4 | Jafarianmohamady Seyedhamed | 5 |
#5 | Subramaniam Srividyabhuvaneswari | 3 |
#6 | Bruce K Patterson | 2 |
#7 | Rodrigues Hallison | 2 |
#8 | Pise Amruta | 2 |
#9 | Yin Fangfang | 2 |
#10 | Francisco Edgar B | 2 |
Publication | Filing date | Title |
---|---|---|
US2020362044A1 | Methods of Treating Cytokine Storm Infections, Including COVID-19, By Inhibiting CCR5/CCL5 (RANTES) Interaction, and Compositions for Practicing the Same | |
WO2020168244A1 | Assaying bladder-associated samples, identifying and treating bladder-associated neoplasia, and kits for use therein | |
WO2020009988A1 | Methods for detecting cancer-related cell populations, screening for metastatic cancer and treatments thereof | |
WO2018098440A1 | Hiv phenotyping assay, methods, compositions and cells for practicing the same | |
EP3510378A1 | Methods of detecting per cell pd-l1 expression and uses thereof | |
US2016349232A1 | Methods of assessing cellular breast samples and compositions for use in practicing the same | |
WO2016014861A1 | Methods of evaluating a cellular sample for latent cellular replication competent hiv-1, and compositions and kits for use in practicing the same | |
CN105122064A | Methods for determining whether a cervical cellular sample should be tested for cervical cancer, and devices and kits for practicing the same | |
EP3217178A2 | Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells | |
EP2258877A2 | HPV E6,E7 mRNA assay and methods of use thereof |